><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahuja</surname><given-names>SD</given-names></name><name><surname>Ashkin</surname><given-names>D</given-names></name><name><surname>Avendano</surname><given-names>M</given-names></name><name><surname>Banerjee</surname><given-names>R</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Bayona</surname><given-names>JN</given-names></name><name><surname>Becerra</surname><given-names>MC</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name><name><surname>Burgos</surname><given-names>M</given-names></name><name><surname>Centis</surname><given-names>R</given-names></name><name><surname>Chan</surname><given-names>ED</given-names></name><name><surname>Chiang</surname><given-names>CY</given-names></name><name><surname>Cox</surname><given-names>H</given-names></name><name><surname>D'Ambrosio</surname><given-names>L</given-names></name><name><surname>DeRiemer</surname><given-names>K</given-names></name><name><surname>Dung</surname><given-names>NH</given-names></name><name><surname>Enarson</surname><given-names>D</given-names></name><name><surname>Falzon</surname><given-names>D</given-names></name><name><surname>Flanagan</surname><given-names>K</given-names></name><name><surname>Flood</surname><given-names>J</given-names></name><name><surname>Garcia-Garcia</surname><given-names>ML</given-names></name><name><surname>Gandhi</surname><given-names>N</given-names></name><name><surname>Granich</surname><given-names>RM</given-names></name><name><surname>Hollm-Delgado</surname><given-names>MG</given-names></name><name><surname>Holtz</surname><given-names>TH</given-names></name><name><surname>Iseman</surname><given-names>MD</given-names></name><name><surname>Jarlsberg</surname><given-names>LG</given-names></name><name><surname>Keshavjee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Koh</surname><given-names>WJ</given-names></name><name><surname>Lancaster</surname><given-names>J</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>de Lange</surname><given-names>WC</given-names></name><name><surname>Leimane</surname><given-names>V</given-names></name><name><surname>Leung</surname><given-names>CC</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name><name><surname>Migliori</surname><given-names>GB</given-names></name><name><surname>Mishustin</surname><given-names>SP</given-names></name><name><surname>Mitnick</surname><given-names>CD</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>O'Riordan</surname><given-names>P</given-names></name><name><surname>Pai</surname><given-names>M</given-names></name><name><surname>Palmero</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Pasvol</surname><given-names>G</given-names></name><name><surname>Pe&#x000f1;a</surname><given-names>J</given-names></name><name><surname>P&#x000e9;rez-Guzm&#x000e1;n</surname><given-names>C</given-names></name><name><surname>Quelapio</surname><given-names>MI</given-names></name><name><surname>Ponce-de-Leon</surname><given-names>A</given-names></name><name><surname>Riekstina</surname><given-names>V</given-names></name><name><surname>Robert</surname><given-names>J</given-names></name><name><surname>Royce</surname><given-names>S</given-names></name><name><surname>Schaaf</surname><given-names>HS</given-names></name><name><surname>Seung</surname><given-names>KJ</given-names></name><name><surname>Shah</surname><given-names>L</given-names></name><name><surname>Shim</surname><given-names>TS</given-names></name><name><surname>Shin</surname><given-names>SS</given-names></name><name><surname>Shiraishi</surname><given-names>Y</given-names></name><name><surname>Sifuentes-Osornio</surname><given-names>J</given-names></name><name><surname>Sotgiu</surname><given-names>G</given-names></name><name><surname>Strand</surname><given-names>MJ</given-names></name><name><surname>Tabarsi</surname><given-names>P</given-names></name><name><surname>Tupasi</surname><given-names>TE</given-names></name><name><surname>van Altena</surname><given-names>R</given-names></name><name><surname>Van der Walt</surname><given-names>M</given-names></name><name><surname>Van der Werf</surname><given-names>TS</given-names></name><name><surname>Vargas</surname><given-names>MH</given-names></name><name><surname>Viiklepp</surname><given-names>P</given-names></name><name><surname>Westenhouse</surname><given-names>J</given-names></name><name><surname>Yew</surname><given-names>WW</given-names></name><name><surname>Yim</surname><given-names>JJ</given-names></name><collab>Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB</collab></person-group><year>2012</year><article-title>Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients</article-title><source>PLOS Medicine</source><volume>9</volume><elocation-id>e1001300</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1001300</pub-id><?supplied-pmid 22952439?><pub-id pub-id-type="pmid">22952439</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzi</surname><given-names>S</given-names></name><name><surname>Hebda</surname><given-names>JK</given-names></name><name><surname>Gavard</surname><given-names>J</given-names></name></person-group><year>2013</year><article-title>Vascular permeability and drug delivery in cancers</article-title><source>Frontiers in Oncology</source><volume>3</volume><pub-id pub-id-type="doi">10.3389/fonc.2013.00211</pub-id><?supplied-pmid 23967403?><pub-id pub-id-type="pmid">23967403</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastos</surname><given-names>ML</given-names></name><name><surname>Hussain</surname><given-names>H</given-names></name><name><surname>Weyer</surname><given-names>K</given-names></name><name><surname>Garcia-Garcia</surname><given-names>L</given-names></name><name><surname>Leimane</surname><given-names>V</given-names></name><name><surname>Leung</surname><given-names>CC</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Pen&#x000e3;</surname><given-names>JM</given-names></name><name><surname>Ponce-de-Leon</surname><given-names>A</given-names></name><name><surname>Seung</surname><given-names>KJ</given-names></name><name><surname>Shean</surname><given-names>K</given-names></name><name><surname>Sifuentes-Osornio</surname><given-names>J</given-names></name><name><surname>Van der Walt</surname><given-names>M</given-names></name><name><surname>Van der Werf</surname><given-names>TS</given-names></name><name><surname>Yew</surname><given-names>WW</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name><collab>Collaborative Group for Meta-analysis of Individual Patient Data in MDR-TB</collab></person-group><year>2014</year><article-title>Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis</article-title><source>Clinical Infectious Diseases</source><volume>59</volume><fpage>1364</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu619</pub-id><?supplied-pmid 25097082?><pub-id pub-id-type="pmid">25097082</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Banchereau</surname><given-names>R</given-names></name><name><surname>Skinner</surname><given-names>J</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Quinn</surname><given-names>C</given-names></name><name><surname>Blankenship</surname><given-names>D</given-names></name><name><surname>Dhawan</surname><given-names>R</given-names></name><name><surname>Cush</surname><given-names>JJ</given-names></name><name><surname>Mejias</surname><given-names>A</given-names></name><name><surname>Ramilo</surname><given-names>O</given-names></name><name><surname>Kon</surname><given-names>OM</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><name><surname>Chaussabel</surname><given-names>D</given-names></name><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group><year>2010</year><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanc</surname><given-names>L</given-names></name><name><surname>Lenaerts</surname><given-names>A</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>Prideaux</surname><given-names>B</given-names></name></person-group><year>2018</year><article-title>Visualization of Mycobacterial Biomarkers and Tuberculosis Drugs in Infected Tissue by MALDI-MS Imaging</article-title><source>Analytical Chemistry</source><volume>90</volume><fpage>6275</fpage><lpage>6282</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.8b00985</pub-id><?supplied-pmid 29668262?><pub-id pub-id-type="pmid">29668262</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Canetti</surname><given-names>G</given-names></name></person-group><year>1955</year><source>The Tubercle Bacillus</source><publisher-loc>New York</publisher-loc><publisher-name>Springer Publishing Company</publisher-name></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canfr&#x000e1;n-Duque</surname><given-names>A</given-names></name><name><surname>Rotllan</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Fern&#x000e1;ndez-Fuertes</surname><given-names>M</given-names></name><name><surname>Ram&#x000ed;rez-Hidalgo</surname><given-names>C</given-names></name><name><surname>Araldi</surname><given-names>E</given-names></name><name><surname>Daimiel</surname><given-names>L</given-names></name><name><surname>Busto</surname><given-names>R</given-names></name><name><surname>Fern&#x000e1;ndez-Hernando</surname><given-names>C</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>Y</given-names></name></person-group><year>2017</year><article-title>Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis</article-title><source>EMBO Molecular Medicine</source><volume>9</volume><fpage>1244</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.15252/emmm.201607492</pub-id><?supplied-pmid 28674080?><pub-id pub-id-type="pmid">28674080</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlier</surname><given-names>MB</given-names></name><name><surname>Scorneaux</surname><given-names>B</given-names></name><name><surname>Zenebergh</surname><given-names>A</given-names></name><name><surname>Desnottes</surname><given-names>JF</given-names></name><name><surname>Tulkens</surname><given-names>PM</given-names></name></person-group><year>1990</year><article-title>Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>26</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1093/jac/26.suppl_B.27</pub-id><?supplied-pmid 2258352?><pub-id pub-id-type="pmid">2258352</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>EH</given-names></name><name><surname>Kurec</surname><given-names>AS</given-names></name><name><surname>Davey</surname><given-names>FR</given-names></name></person-group><year>1981</year><article-title>Cell volumes of normal and malignant mononuclear cells</article-title><source>Journal of Clinical Pathology</source><volume>34</volume><fpage>1083</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.1136/jcp.34.10.1083</pub-id><?supplied-pmid 6975780?><pub-id pub-id-type="pmid">6975780</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Gardete</surname><given-names>S</given-names></name><name><surname>Jansen</surname><given-names>RS</given-names></name><name><surname>Shetty</surname><given-names>A</given-names></name><name><surname>Dick</surname><given-names>T</given-names></name><name><surname>Rhee</surname><given-names>KY</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name></person-group><year>2018</year><article-title>Verapamil Targets Membrane Energetics in <italic>Mycobacterium tuberculosis</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>62</volume><elocation-id>e02107</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.02107-17</pub-id><pub-id pub-id-type="pmid">29463541</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallenga</surname><given-names>T</given-names></name><name><surname>Schaible</surname><given-names>UE</given-names></name></person-group><year>2016</year><article-title>Neutrophils in tuberculosis--first line of defence or booster of disease and targets for host-directed therapy?</article-title><source>Pathogens and Disease</source><volume>74</volume><elocation-id>ftw012</elocation-id><pub-id pub-id-type="doi">10.1093/femspd/ftw012</pub-id><?supplied-pmid 26903072?><pub-id pub-id-type="pmid">26903072</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dannenberg</surname><given-names>AM</given-names></name></person-group><year>2006</year><source>Jr&#x000a0;Pathogenesis of Human Pulmonary Tuberculosis</source><publisher-loc>Washigton DC</publisher-loc><publisher-name>ASM Press</publisher-name><pub-id pub-id-type="doi">10.1128/9781555815684</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dartois</surname><given-names>V</given-names></name></person-group><year>2014</year><article-title>The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells</article-title><source>Nature Reviews Microbiology</source><volume>12</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3200</pub-id><?supplied-pmid 24487820?><pub-id pub-id-type="pmid">24487820</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>M</given-names></name><name><surname>Via</surname><given-names>LE</given-names></name><name><surname>Kamoun</surname><given-names>WS</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Seano</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>DM</given-names></name><name><surname>Schimel</surname><given-names>D</given-names></name><name><surname>England</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>JD</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name><name><surname>Jain</surname><given-names>RK</given-names></name></person-group><year>2015</year><article-title>Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery</article-title><source>PNAS</source><volume>112</volume><fpage>1827</fpage><lpage>1832</lpage><pub-id pub-id-type="doi">10.1073/pnas.1424563112</pub-id><?supplied-pmid 25624495?><pub-id pub-id-type="pmid">25624495</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paolo</surname><given-names>A</given-names></name><name><surname>Bocci</surname><given-names>G</given-names></name></person-group><year>2007</year><article-title>Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification</article-title><source>Current Oncology Reports</source><volume>9</volume><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1007/s11912-007-0006-3</pub-id><?supplied-pmid 17288875?><pub-id pub-id-type="pmid">17288875</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diacon</surname><given-names>AH</given-names></name><name><surname>Dawson</surname><given-names>R</given-names></name><name><surname>von Groote-Bidlingmaier</surname><given-names>F</given-names></name><name><surname>Symons</surname><given-names>G</given-names></name><name><surname>Venter</surname><given-names>A</given-names></name><name><surname>Donald</surname><given-names>PR</given-names></name><name><surname>van Niekerk</surname><given-names>C</given-names></name><name><surname>Everitt</surname><given-names>D</given-names></name><name><surname>Winter</surname><given-names>H</given-names></name><name><surname>Becker</surname><given-names>P</given-names></name><name><surname>Mendel</surname><given-names>CM</given-names></name><name><surname>Spigelman</surname><given-names>MK</given-names></name></person-group><year>2012</year><article-title>14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial</article-title><source>The Lancet</source><volume>380</volume><fpage>986</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)61080-0</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diedrich</surname><given-names>CR</given-names></name><name><surname>O'Hern</surname><given-names>J</given-names></name><name><surname>Gutierrez</surname><given-names>MG</given-names></name><name><surname>Allie</surname><given-names>N</given-names></name><name><surname>Papier</surname><given-names>P</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Coussens</surname><given-names>AK</given-names></name><name><surname>Wainwright</surname><given-names>H</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group><year>2016</year><article-title>Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas</article-title><source>Journal of Infectious Diseases</source><volume>214</volume><fpage>1309</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw313</pub-id><?supplied-pmid 27462092?><pub-id pub-id-type="pmid">27462092</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falzon</surname><given-names>D</given-names></name><name><surname>Gandhi</surname><given-names>N</given-names></name><name><surname>Migliori</surname><given-names>GB</given-names></name><name><surname>Sotgiu</surname><given-names>G</given-names></name><name><surname>Cox</surname><given-names>HS</given-names></name><name><surname>Holtz</surname><given-names>TH</given-names></name><name><surname>Hollm-Delgado</surname><given-names>MG</given-names></name><name><surname>Keshavjee</surname><given-names>S</given-names></name><name><surname>DeRiemer</surname><given-names>K</given-names></name><name><surname>Centis</surname><given-names>R</given-names></name><name><surname>D'Ambrosio</surname><given-names>L</given-names></name><name><surname>Lange</surname><given-names>CG</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name><collab>Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB</collab></person-group><year>2013</year><article-title>Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes</article-title><source>European Respiratory Journal</source><volume>42</volume><fpage>156</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1183/09031936.00134712</pub-id><?supplied-pmid 23100499?><pub-id pub-id-type="pmid">23100499</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerstner</surname><given-names>ER</given-names></name><name><surname>Duda</surname><given-names>DG</given-names></name><name><surname>di Tomaso</surname><given-names>E</given-names></name><name><surname>Ryg</surname><given-names>PA</given-names></name><name><surname>Loeffler</surname><given-names>JS</given-names></name><name><surname>Sorensen</surname><given-names>AG</given-names></name><name><surname>Ivy</surname><given-names>P</given-names></name><name><surname>Jain</surname><given-names>RK</given-names></name><name><surname>Batchelor</surname><given-names>TT</given-names></name></person-group><year>2009</year><article-title>VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer</article-title><source>Nature Reviews Clinical Oncology</source><volume>6</volume><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2009.14</pub-id><?supplied-pmid 19333229?><pub-id pub-id-type="pmid">19333229</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname><given-names>SH</given-names></name></person-group><year>2016</year><article-title>The role of moxifloxacin in tuberculosis therapy</article-title><source>European Respiratory Review</source><volume>25</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1183/16000617.0085-2015</pub-id><?supplied-pmid 26929417?><pub-id pub-id-type="pmid">26929417</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giordano</surname><given-names>S</given-names></name><name><surname>Zucchetti</surname><given-names>M</given-names></name><name><surname>Decio</surname><given-names>A</given-names></name><name><surname>Cesca</surname><given-names>M</given-names></name><name><surname>Fuso Nerini</surname><given-names>I</given-names></name><name><surname>Maiezza</surname><given-names>M</given-names></name><name><surname>Ferrari</surname><given-names>M</given-names></name><name><surname>Licandro</surname><given-names>SA</given-names></name><name><surname>Frapolli</surname><given-names>R</given-names></name><name><surname>Giavazzi</surname><given-names>R</given-names></name><name><surname>Maurizio</surname><given-names>D</given-names></name><name><surname>Davoli</surname><given-names>E</given-names></name><name><surname>Morosi</surname><given-names>L</given-names></name></person-group><year>2016</year><article-title>Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>39284</elocation-id><pub-id pub-id-type="doi">10.1038/srep39284</pub-id><?supplied-pmid 28000726?><pub-id pub-id-type="pmid">28000726</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrichs</surname><given-names>MT</given-names></name><name><surname>Vashakidze</surname><given-names>S</given-names></name><name><surname>Nikolaishvili</surname><given-names>K</given-names></name><name><surname>Sabulua</surname><given-names>I</given-names></name><name><surname>Tukvadze</surname><given-names>N</given-names></name><name><surname>Bablishvili</surname><given-names>N</given-names></name><name><surname>Gogishvili</surname><given-names>S</given-names></name><name><surname>Little</surname><given-names>BP</given-names></name><name><surname>Bernheim</surname><given-names>A</given-names></name><name><surname>Guarner</surname><given-names>J</given-names></name><name><surname>Peloquin</surname><given-names>CA</given-names></name><name><surname>Blumberg</surname><given-names>HM</given-names></name><name><surname>Derendorf</surname><given-names>H</given-names></name><name><surname>Kempker</surname><given-names>RR</given-names></name></person-group><year>2018</year><article-title>Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study</article-title><source>Journal of Antimicrobial Chemotherapy</source><volume>73</volume><fpage>477</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1093/jac/dkx421</pub-id><?supplied-pmid 29186509?><pub-id pub-id-type="pmid">29186509</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinsenkamp</surname><given-names>I</given-names></name><name><surname>Schulz</surname><given-names>S</given-names></name><name><surname>Roscher</surname><given-names>M</given-names></name><name><surname>Suhr</surname><given-names>AM</given-names></name><name><surname>Meyer</surname><given-names>B</given-names></name><name><surname>Munteanu</surname><given-names>B</given-names></name><name><surname>Fuchser</surname><given-names>J</given-names></name><name><surname>Schoenberg</surname><given-names>SO</given-names></name><name><surname>Ebert</surname><given-names>MP</given-names></name><name><surname>W&#x000e4;ngler</surname><given-names>B</given-names></name><name><surname>Hopf</surname><given-names>C</given-names></name><name><surname>Burgermeister</surname><given-names>E</given-names></name></person-group><year>2016</year><article-title>Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer</article-title><source>Neoplasia</source><volume>18</volume><fpage>500</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.neo.2016.07.002</pub-id><?supplied-pmid 27566106?><pub-id pub-id-type="pmid">27566106</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>SM</given-names></name><name><surname>Gruppo</surname><given-names>V</given-names></name><name><surname>Brooks</surname><given-names>E</given-names></name><name><surname>Gilliland</surname><given-names>J</given-names></name><name><surname>Scherman</surname><given-names>M</given-names></name><name><surname>Reichlen</surname><given-names>MJ</given-names></name><name><surname>Leistikow</surname><given-names>R</given-names></name><name><surname>Kramnik</surname><given-names>I</given-names></name><name><surname>Nuermberger</surname><given-names>EL</given-names></name><name><surname>Voskuil</surname><given-names>MI</given-names></name><name><surname>Lenaerts</surname><given-names>AJ</given-names></name></person-group><year>2014</year><article-title>Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>58</volume><fpage>4026</fpage><lpage>4034</lpage><pub-id pub-id-type="doi">10.1128/AAC.02565-14</pub-id><pub-id pub-id-type="pmid">24798275</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>SM</given-names></name><name><surname>Prideaux</surname><given-names>B</given-names></name><name><surname>Lyon</surname><given-names>ER</given-names></name><name><surname>Zimmerman</surname><given-names>MD</given-names></name><name><surname>Brooks</surname><given-names>EJ</given-names></name><name><surname>Schrupp</surname><given-names>CA</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Reichlen</surname><given-names>MJ</given-names></name><name><surname>Asay</surname><given-names>BC</given-names></name><name><surname>Voskuil</surname><given-names>MI</given-names></name><name><surname>Nuermberger</surname><given-names>EL</given-names></name><name><surname>Andries</surname><given-names>K</given-names></name><name><surname>Lyons</surname><given-names>MA</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>Lenaerts</surname><given-names>AJ</given-names></name></person-group><year>2016</year><article-title>Bedaquiline and pyrazinamide treatment responses are affected by pulmonary lesion heterogeneity in <italic>Mycobacterium tuberculosis</italic> Infected C3HeB/FeJ Mice</article-title><source>ACS Infectious Diseases</source><volume>2</volume><fpage>251</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.5b00127</pub-id><?supplied-pmid 27227164?><pub-id pub-id-type="pmid">27227164</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>RD</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Piao</surname><given-names>YJ</given-names></name></person-group><year>2010</year><article-title>The morphometrical analysis on the ultrastructure of A549 cells</article-title><source>Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie</source><volume>51</volume><fpage>663</fpage><lpage>667</lpage><?supplied-pmid 21103623?><pub-id pub-id-type="pmid">21103623</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren</surname><given-names>L</given-names></name><name><surname>Bosse</surname><given-names>M</given-names></name><name><surname>Marquez</surname><given-names>D</given-names></name><name><surname>Angoshtari</surname><given-names>R</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Varma</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>SR</given-names></name><name><surname>Kurian</surname><given-names>A</given-names></name><name><surname>Van Valen</surname><given-names>D</given-names></name><name><surname>West</surname><given-names>R</given-names></name><name><surname>Bendall</surname><given-names>SC</given-names></name><name><surname>Angelo</surname><given-names>M</given-names></name></person-group><year>2018</year><article-title>A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging</article-title><source>Cell</source><volume>174</volume><fpage>1373</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.08.039</pub-id><?supplied-pmid 30193111?><pub-id pub-id-type="pmid">30193111</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmey</surname><given-names>JM</given-names></name><name><surname>Huynh</surname><given-names>JP</given-names></name><name><surname>Weiss</surname><given-names>LA</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Kambal</surname><given-names>A</given-names></name><name><surname>Debnath</surname><given-names>J</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name><name><surname>Stallings</surname><given-names>CL</given-names></name></person-group><year>2015</year><article-title>Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection</article-title><source>Nature</source><volume>528</volume><fpage>565</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1038/nature16451</pub-id><?supplied-pmid 26649827?><pub-id pub-id-type="pmid">26649827</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Leong</surname><given-names>FJ</given-names></name><name><surname>Eum</surname><given-names>SY</given-names></name><name><surname>Via</surname><given-names>LE</given-names></name><name><surname>CEr</surname><given-names>B</given-names></name></person-group><year>2011</year><chapter-title>Pathology of Tuberculosis in the Human Lung</chapter-title><person-group person-group-type="editor"><name><surname>Leong VDaTD</surname><given-names>F. J</given-names></name></person-group><source>A Color Atlas of Comparative Pathology of Pulmonary Tuberculosis</source><publisher-name>CRC Press</publisher-name><fpage>53</fpage><lpage>81</lpage></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Ide</surname><given-names>JL</given-names></name><name><surname>Norton</surname><given-names>I</given-names></name><name><surname>Marchionni</surname><given-names>MA</given-names></name><name><surname>Ebling</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>LY</given-names></name><name><surname>Davis</surname><given-names>E</given-names></name><name><surname>Sauvageot</surname><given-names>CM</given-names></name><name><surname>Kesari</surname><given-names>S</given-names></name><name><surname>Kellersberger</surname><given-names>KA</given-names></name><name><surname>Easterling</surname><given-names>ML</given-names></name><name><surname>Santagata</surname><given-names>S</given-names></name><name><surname>Stuart</surname><given-names>DD</given-names></name><name><surname>Alberta</surname><given-names>J</given-names></name><name><surname>Agar</surname><given-names>JN</given-names></name><name><surname>Stiles</surname><given-names>CD</given-names></name><name><surname>Agar</surname><given-names>NY</given-names></name></person-group><year>2013</year><article-title>Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging</article-title><source>Scientific Reports</source><volume>3</volume><elocation-id>2859</elocation-id><pub-id pub-id-type="doi">10.1038/srep02859</pub-id><?supplied-pmid 24091529?><pub-id pub-id-type="pmid">24091529</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorkowski</surname><given-names>S</given-names></name><name><surname>Kratz</surname><given-names>M</given-names></name><name><surname>Wenner</surname><given-names>C</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Weitkamp</surname><given-names>B</given-names></name><name><surname>Fobker</surname><given-names>M</given-names></name><name><surname>Reinhardt</surname><given-names>J</given-names></name><name><surname>Rauterberg</surname><given-names>J</given-names></name><name><surname>Galinski</surname><given-names>EA</given-names></name><name><surname>Cullen</surname><given-names>P</given-names></name></person-group><year>2001</year><article-title>Expression of the ATP-binding cassette transporter gene ABCG1 (ABC8) in Tangier disease</article-title><source>Biochemical and Biophysical Research Communications</source><volume>283</volume><fpage>821</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.4863</pub-id><?supplied-pmid 11350058?><pub-id pub-id-type="pmid">11350058</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Ohtsu</surname><given-names>N</given-names></name><name><surname>Oguma</surname><given-names>T</given-names></name><name><surname>Ohnishi</surname><given-names>T</given-names></name><name><surname>Atsumi</surname><given-names>R</given-names></name><name><surname>Tamai</surname><given-names>I</given-names></name></person-group><year>2007</year><article-title>Identification of influx transporter for the quinolone antibacterial agent levofloxacin</article-title><source>Molecular Pharmaceutics</source><volume>4</volume><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1021/mp060082j</pub-id><?supplied-pmid 17274666?><pub-id pub-id-type="pmid">17274666</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marko-Varga</surname><given-names>G</given-names></name><name><surname>Fehniger</surname><given-names>TE</given-names></name><name><surname>Rezeli</surname><given-names>M</given-names></name><name><surname>D&#x000f6;me</surname><given-names>B</given-names></name><name><surname>Laurell</surname><given-names>T</given-names></name><name><surname>V&#x000e9;gv&#x000e1;ri</surname><given-names>A</given-names></name></person-group><year>2011</year><article-title>Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging</article-title><source>Journal of Proteomics</source><volume>74</volume><fpage>982</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2011.03.019</pub-id><?supplied-pmid 21440690?><pub-id pub-id-type="pmid">21440690</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michael</surname><given-names>DR</given-names></name><name><surname>Ashlin</surname><given-names>TG</given-names></name><name><surname>Davies</surname><given-names>CS</given-names></name><name><surname>Gallagher</surname><given-names>H</given-names></name><name><surname>Stoneman</surname><given-names>TW</given-names></name><name><surname>Buckley</surname><given-names>ML</given-names></name><name><surname>Ramji</surname><given-names>DP</given-names></name></person-group><year>2013</year><article-title>Differential regulation of macropinocytosis in macrophages by cytokines: implications for foam cell formation and atherosclerosis</article-title><source>Cytokine</source><volume>64</volume><fpage>357</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2013.05.016</pub-id><?supplied-pmid 23791479?><pub-id pub-id-type="pmid">23791479</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michot</surname><given-names>J-M</given-names></name><name><surname>Seral</surname><given-names>C</given-names></name><name><surname>Van Bambeke</surname><given-names>F</given-names></name><name><surname>Mingeot-Leclercq</surname><given-names>M-P</given-names></name><name><surname>Tulkens</surname><given-names>PM</given-names></name></person-group><year>2005</year><article-title>Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 Macrophages</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>49</volume><fpage>2429</fpage><lpage>2437</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.6.2429-2437.2005</pub-id><pub-id pub-id-type="pmid">15917543</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michot</surname><given-names>J-M</given-names></name><name><surname>Heremans</surname><given-names>MF</given-names></name><name><surname>Caceres</surname><given-names>NE</given-names></name><name><surname>Mingeot-Leclercq</surname><given-names>M-P</given-names></name><name><surname>Tulkens</surname><given-names>PM</given-names></name><name><surname>Van Bambeke</surname><given-names>F</given-names></name></person-group><year>2006</year><article-title>Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophages</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>50</volume><fpage>1689</fpage><lpage>1695</lpage><pub-id pub-id-type="doi">10.1128/AAC.50.5.1689-1695.2006</pub-id><pub-id pub-id-type="pmid">16641436</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>BB</given-names></name><name><surname>Lovewell</surname><given-names>RR</given-names></name><name><surname>Olive</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Eugenin</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>CM</given-names></name><name><surname>Phuah</surname><given-names>JY</given-names></name><name><surname>Long</surname><given-names>JE</given-names></name><name><surname>Dubuke</surname><given-names>ML</given-names></name><name><surname>Palace</surname><given-names>SG</given-names></name><name><surname>Goguen</surname><given-names>JD</given-names></name><name><surname>Baker</surname><given-names>RE</given-names></name><name><surname>Nambi</surname><given-names>S</given-names></name><name><surname>Mishra</surname><given-names>R</given-names></name><name><surname>Booty</surname><given-names>MG</given-names></name><name><surname>Baer</surname><given-names>CE</given-names></name><name><surname>Shaffer</surname><given-names>SA</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>McCormick</surname><given-names>BA</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name></person-group><year>2017</year><article-title>Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis</article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>17072</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.72</pub-id><?supplied-pmid 28504669?><pub-id pub-id-type="pmid">28504669</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulgaonkar</surname><given-names>A</given-names></name><name><surname>Venitz</surname><given-names>J</given-names></name><name><surname>Gr&#x000fc;ndemann</surname><given-names>D</given-names></name><name><surname>Sweet</surname><given-names>DH</given-names></name></person-group><year>2013</year><article-title>Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>2705</fpage><lpage>2711</lpage><pub-id pub-id-type="doi">10.1128/AAC.02289-12</pub-id><pub-id pub-id-type="pmid">23545524</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemiec</surname><given-names>MJ</given-names></name><name><surname>De Samber</surname><given-names>B</given-names></name><name><surname>Garrevoet</surname><given-names>J</given-names></name><name><surname>Vergucht</surname><given-names>E</given-names></name><name><surname>Vekemans</surname><given-names>B</given-names></name><name><surname>De Rycke</surname><given-names>R</given-names></name><name><surname>Bj&#x000f6;rn</surname><given-names>E</given-names></name><name><surname>Sandblad</surname><given-names>L</given-names></name><name><surname>Wellenreuther</surname><given-names>G</given-names></name><name><surname>Falkenberg</surname><given-names>G</given-names></name><name><surname>Cloetens</surname><given-names>P</given-names></name><name><surname>Vincze</surname><given-names>L</given-names></name><name><surname>Urban</surname><given-names>CF</given-names></name></person-group><year>2015</year><article-title>Trace element landscape of resting and activated human neutrophils on the sub-micrometer level</article-title><source>Metallomics</source><volume>7</volume><fpage>996</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1039/C4MT00346B</pub-id><?supplied-pmid 25832493?><pub-id pub-id-type="pmid">25832493</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyron</surname><given-names>P</given-names></name><name><surname>Vaubourgeix</surname><given-names>J</given-names></name><name><surname>Poquet</surname><given-names>Y</given-names></name><name><surname>Levillain</surname><given-names>F</given-names></name><name><surname>Botanch</surname><given-names>C</given-names></name><name><surname>Bardou</surname><given-names>F</given-names></name><name><surname>Daff&#x000e9;</surname><given-names>M</given-names></name><name><surname>Emile</surname><given-names>JF</given-names></name><name><surname>Marchou</surname><given-names>B</given-names></name><name><surname>Cardona</surname><given-names>PJ</given-names></name><name><surname>de Chastellier</surname><given-names>C</given-names></name><name><surname>Altare</surname><given-names>F</given-names></name></person-group><year>2008</year><article-title>Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence</article-title><source>PLOS Pathogens</source><volume>4</volume><elocation-id>e1000204</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000204</pub-id><?supplied-pmid 19002241?><pub-id pub-id-type="pmid">19002241</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pienaar</surname><given-names>E</given-names></name><name><surname>Sarathy</surname><given-names>J</given-names></name><name><surname>Prideaux</surname><given-names>B</given-names></name><name><surname>Dietzold</surname><given-names>J</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>Kirschner</surname><given-names>DE</given-names></name><name><surname>Linderman</surname><given-names>JJ</given-names></name></person-group><year>2017</year><article-title>Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach</article-title><source>PLOS Computational Biology</source><volume>13</volume><elocation-id>e1005650</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005650</pub-id><?supplied-pmid 28817561?><pub-id pub-id-type="pmid">28817561</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prideaux</surname><given-names>B</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>Staab</surname><given-names>D</given-names></name><name><surname>Weiner</surname><given-names>DM</given-names></name><name><surname>Goh</surname><given-names>A</given-names></name><name><surname>Via</surname><given-names>LE</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name><name><surname>Stoeckli</surname><given-names>M</given-names></name></person-group><year>2011</year><article-title>High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions</article-title><source>Analytical Chemistry</source><volume>83</volume><fpage>2112</fpage><lpage>2118</lpage><pub-id pub-id-type="doi">10.1021/ac1029049</pub-id><?supplied-pmid 21332183?><pub-id pub-id-type="pmid">21332183</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prideaux</surname><given-names>B</given-names></name><name><surname>Via</surname><given-names>LE</given-names></name><name><surname>Zimmerman</surname><given-names>MD</given-names></name><name><surname>Eum</surname><given-names>S</given-names></name><name><surname>Sarathy</surname><given-names>J</given-names></name><name><surname>O'Brien</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Kaya</surname><given-names>F</given-names></name><name><surname>Weiner</surname><given-names>DM</given-names></name><name><surname>Chen</surname><given-names>PY</given-names></name><name><surname>Song</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Shim</surname><given-names>TS</given-names></name><name><surname>Cho</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Cho</surname><given-names>SN</given-names></name><name><surname>Olivier</surname><given-names>KN</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name></person-group><year>2015a</year><article-title>The association between sterilizing activity and drug distribution into tuberculosis lesions</article-title><source>Nature Medicine</source><volume>21</volume><fpage>1223</fpage><lpage>1227</lpage><pub-id pub-id-type="doi">10.1038/nm.3937</pub-id><?supplied-pmid 26343800?><pub-id pub-id-type="pmid">26343800</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prideaux</surname><given-names>B</given-names></name><name><surname>ElNaggar</surname><given-names>MS</given-names></name><name><surname>Zimmerman</surname><given-names>M</given-names></name><name><surname>Wiseman</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name></person-group><year>2015b</year><article-title>Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling</article-title><source>International Journal of Mass Spectrometry</source><volume>377</volume><fpage>699</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1016/j.ijms.2014.08.024</pub-id><?supplied-pmid 26185484?><pub-id pub-id-type="pmid">26185484</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rippley</surname><given-names>RK</given-names></name><name><surname>Stokes</surname><given-names>CL</given-names></name></person-group><year>1995</year><article-title>Effects of cellular pharmacology on drug distribution in tissues</article-title><source>Biophysical Journal</source><volume>69</volume><fpage>825</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(95)79956-8</pub-id><?supplied-pmid 8519983?><pub-id pub-id-type="pmid">8519983</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudin</surname><given-names>DE</given-names></name><name><surname>Gao</surname><given-names>PX</given-names></name><name><surname>Cao</surname><given-names>CX</given-names></name><name><surname>Neu</surname><given-names>HC</given-names></name><name><surname>Silverstein</surname><given-names>SC</given-names></name></person-group><year>1992</year><article-title>Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages</article-title><source>Journal of Experimental Medicine</source><volume>176</volume><fpage>1439</fpage><lpage>1447</lpage><pub-id pub-id-type="doi">10.1084/jem.176.5.1439</pub-id><?supplied-pmid 1402686?><pub-id pub-id-type="pmid">1402686</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><year>2007</year><article-title>Who puts the tubercle in tuberculosis?</article-title><source>Nature Reviews Microbiology</source><volume>5</volume><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1538</pub-id><?supplied-pmid 17160001?><pub-id pub-id-type="pmid">17160001</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saggar</surname><given-names>JK</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>Q</given-names></name><name><surname>Tannock</surname><given-names>IF</given-names></name></person-group><year>2013</year><article-title>The tumor microenvironment and strategies to improve drug distribution</article-title><source>Frontiers in Oncology</source><volume>3</volume><elocation-id>154</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2013.00154</pub-id><?supplied-pmid 23772420?><pub-id pub-id-type="pmid">23772420</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salphati</surname><given-names>L</given-names></name><name><surname>Shahidi-Latham</surname><given-names>S</given-names></name><name><surname>Quiason</surname><given-names>C</given-names></name><name><surname>Barck</surname><given-names>K</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name><name><surname>Alicke</surname><given-names>B</given-names></name><name><surname>Pang</surname><given-names>J</given-names></name><name><surname>Carano</surname><given-names>RA</given-names></name><name><surname>Olivero</surname><given-names>AG</given-names></name><name><surname>Phillips</surname><given-names>HS</given-names></name></person-group><year>2014</year><article-title>Distribution of the phosphatidylinositol 3-kinase inhibitors Pictilisib (GDC-0941) and GNE-317 in U87 and GS2 intracranial glioblastoma models-assessment by matrix-assisted laser desorption ionization imaging</article-title><source>Drug Metabolism and Disposition</source><volume>42</volume><fpage>1110</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1124/dmd.114.057513</pub-id><?supplied-pmid 24754926?><pub-id pub-id-type="pmid">24754926</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarathy</surname><given-names>JP</given-names></name><name><surname>Via</surname><given-names>LE</given-names></name><name><surname>Weiner</surname><given-names>D</given-names></name><name><surname>Blanc</surname><given-names>L</given-names></name><name><surname>Boshoff</surname><given-names>H</given-names></name><name><surname>Eugenin</surname><given-names>EA</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name><name><surname>Dartois</surname><given-names>VA</given-names></name></person-group><year>2018</year><article-title>Extreme drug tolerance of Mycobacterium tuberculosis in Caseum</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>62</volume><elocation-id>e02266</elocation-id><pub-id pub-id-type="pmid">29203492</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savic</surname><given-names>RM</given-names></name><name><surname>Karlsson</surname><given-names>MO</given-names></name></person-group><year>2009</year><article-title>Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions</article-title><source>The AAPS Journal</source><volume>11</volume><fpage>558</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1208/s12248-009-9133-0</pub-id><?supplied-pmid 19649712?><pub-id pub-id-type="pmid">19649712</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scordo</surname><given-names>JM</given-names></name><name><surname>Knoell</surname><given-names>DL</given-names></name><name><surname>Torrelles</surname><given-names>JB</given-names></name></person-group><year>2016</year><article-title>Alveolar Epithelial Cells in Mycobacterium tuberculosis Infection: Active Players or Innocent Bystanders?</article-title><source>Journal of Innate Immunity</source><volume>8</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1159/000439275</pub-id><?supplied-pmid 26384325?><pub-id pub-id-type="pmid">26384325</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subbian</surname><given-names>S</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>O'Brien</surname><given-names>P</given-names></name><name><surname>Parsons</surname><given-names>S</given-names></name><name><surname>Peixoto</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>L</given-names></name><name><surname>Fallows</surname><given-names>D</given-names></name><name><surname>Kaplan</surname><given-names>G</given-names></name></person-group><year>2011</year><article-title>Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response</article-title><source>Open Biology</source><volume>1</volume><elocation-id>110016</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.110016</pub-id><?supplied-pmid 22645653?><pub-id pub-id-type="pmid">22645653</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tailleux</surname><given-names>L</given-names></name><name><surname>Neyrolles</surname><given-names>O</given-names></name><name><surname>Honor&#x000e9;-Bouakline</surname><given-names>S</given-names></name><name><surname>Perret</surname><given-names>E</given-names></name><name><surname>Sanchez</surname><given-names>F</given-names></name><name><surname>Abastado</surname><given-names>JP</given-names></name><name><surname>Lagrange</surname><given-names>PH</given-names></name><name><surname>Gluckman</surname><given-names>JC</given-names></name><name><surname>Rosenzwajg</surname><given-names>M</given-names></name><name><surname>Herrmann</surname><given-names>JL</given-names></name></person-group><year>2003</year><article-title>Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells</article-title><source>The Journal of Immunology</source><volume>170</volume><fpage>1939</fpage><lpage>1948</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.170.4.1939</pub-id><?supplied-pmid 12574362?><pub-id pub-id-type="pmid">12574362</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname><given-names>L</given-names></name><name><surname>Denti</surname><given-names>P</given-names></name><name><surname>Wiesner</surname><given-names>L</given-names></name><name><surname>Warner</surname><given-names>DF</given-names></name></person-group><year>2018</year><article-title>Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development</article-title><source>IUBMB Life</source><volume>70</volume><fpage>926</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1002/iub.1866</pub-id><?supplied-pmid 29934964?><pub-id pub-id-type="pmid">29934964</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wainberg</surname><given-names>M</given-names></name><name><surname>Merico</surname><given-names>D</given-names></name><name><surname>Delong</surname><given-names>A</given-names></name><name><surname>Frey</surname><given-names>BJ</given-names></name></person-group><year>2018</year><article-title>Deep learning in biomedicine</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>829</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1038/nbt.4233</pub-id><?supplied-pmid 30188539?><pub-id pub-id-type="pmid">30188539</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname><given-names>M</given-names></name><name><surname>Gelfond</surname><given-names>J</given-names></name><name><surname>Johnson-Pais</surname><given-names>TL</given-names></name><name><surname>Engle</surname><given-names>M</given-names></name><name><surname>Peloquin</surname><given-names>CA</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Sizemore</surname><given-names>EE</given-names></name><name><surname>Mac Kenzie</surname><given-names>WR</given-names></name></person-group><year>2018</year><article-title>Elevated Plasma Moxifloxacin Concentrations and <italic>SLCO1B1</italic> g.&#x02212;11187G&#x0003e;A Polymorphism in Adults with Pulmonary Tuberculosis</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>62</volume><elocation-id>e01802</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.01802-17</pub-id><pub-id pub-id-type="pmid">29463526</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zimmerman</surname><given-names>MD</given-names></name><name><surname>Chen</surname><given-names>KY</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>DJ</given-names></name><name><surname>Kaya</surname><given-names>F</given-names></name><name><surname>Rakhilin</surname><given-names>N</given-names></name><name><surname>Nazarova</surname><given-names>EV</given-names></name><name><surname>Bu</surname><given-names>P</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name></person-group><year>2018</year><article-title>Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1006974</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006974</pub-id><?supplied-pmid 29698476?><pub-id pub-id-type="pmid">29698476</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>M</given-names></name><name><surname>Lestner</surname><given-names>J</given-names></name><name><surname>Prideaux</surname><given-names>B</given-names></name><name><surname>O'Brien</surname><given-names>P</given-names></name><name><surname>Dias-Freedman</surname><given-names>I</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Dietzold</surname><given-names>J</given-names></name><name><surname>Daudelin</surname><given-names>I</given-names></name><name><surname>Kaya</surname><given-names>F</given-names></name><name><surname>Blanc</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>P-Y</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Salgame</surname><given-names>P</given-names></name><name><surname>Sarathy</surname><given-names>J</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name></person-group><year>2017</year><article-title>Ethambutol Partitioning in tuberculous pulmonary lesions explains its clinical efficacy</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>61</volume><elocation-id>e00924</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00924-17</pub-id><pub-id pub-id-type="pmid">28696241</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>M</given-names></name><name><surname>Blanc</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>P-Y</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>Prideaux</surname><given-names>B</given-names></name></person-group><year>2018</year><article-title>Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry (LCM-LC/MS)</article-title><source>Journal of Visualized Experiments</source><volume>134</volume><fpage>e57402</fpage><pub-id pub-id-type="doi">10.3791/57402</pub-id></element-citation></ref></